MAT-SU REGIONAL MED CTR — History
CCN 020006 | 3-year financial timeline | COVID resilience: 70/100
🛡️ Public data only — no PHI permitted on this instance.
$302M
Latest Revenue (FY2022)
+13.7%
Revenue CAGR (3yr)
26.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $233M | $284M | $302M | +6.2% | +13.7% |
| Operating Expenses | $176M | $211M | $221M | +4.9% | +12.2% |
| Operating Margin | 24.7% | 25.8% | 26.7% | +3.6% | +4.0% |
| Net Income | $58M | $73M | $81M | +10.0% | +18.2% |
| Licensed Beds | 125 | 125 | 125 | +0.0% | +0.0% |
| Total Patient Days | 21,704 | 26,119 | 25,076 | -4.0% | +7.5% |
| Medicare Day % | 40% | 40% | 43% | +6.9% | +3.7% |
| Medicaid Day % | 32% | 35% | 33% | -6.0% | +0.7% |
COVID Impact & Recovery
Resilience Score: 70/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +29.3% ($233M → $302M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+13.7%
This Hospital
+7.6%
State Avg
Latest Margin
26.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $336M | 27.7% |
| FY2024 (proj) | $370M | 28.8% |
| FY2025 (proj) | $404M | 29.8% |